Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

This study is currently recruiting participants.

Verified February 2012 by M.D. Anderson Cancer Center

Study NCT00857389 Information provided by M.D. Anderson Cancer Center

First Received on March 5, 2009. Last Updated on February 27, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Stem Cell Transplantation
Leukemia
Lymphoma

More general conditions related to this trial

Interventions listed in this trial

Thiotepa
Clofarabine
Busulfan
Thymoglobulin (ATG)
G-CSF (Filgrastim)

Additional drug interventions recognized in this trial

Antilymphocyte Serum
Lenograstim

More general drug interventions related to this trial

Sponsors listed in this trial